Literature DB >> 20452337

Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro.

Ava J Y Guo1, Heidi Q Xie, Roy C Y Choi, Ken Y Z Zheng, Cathy W C Bi, Sherry L Xu, Tina T X Dong, Karl W K Tsim.   

Abstract

Acetylcholinesterase (AChE) inhibitors are widely used for the treatment of Alzheimer's disease (AD). Several AChE inhibitors, e.g. rivastigmine, galantamine and huperzine are originating from plants, suggesting that herbs could potentially serve as sources for novel AChE inhibitors. Here, we searched potential AChE inhibitors from flavonoids, a group of naturally occurring compounds in plants or traditional Chinese medicines (TCM). Twenty-one flavonoids, covered different subclasses, were tested for their potential function in inhibiting AChE activity from the brain in vitro. Among all the tested flavonoids, galangin, a flavonol isolated from Rhizoma Alpiniae Officinarum, the rhizomes of Alpiniae officinarum (Hance.) showed an inhibitory effect on AChE activity with the highest inhibition by over 55% and an IC(50) of 120 microM and an enzyme-flavonoid inhibition constant (K(i)) of 74 microM. The results suggest that flavonoids could be potential candidates for further development of new drugs against AD. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452337     DOI: 10.1016/j.cbi.2010.05.002

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  17 in total

Review 1.  Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer's disease.

Authors:  Nasimudeen R Jabir; Fayaz Rahman Khan; Shams Tabrez
Journal:  CNS Neurosci Ther       Date:  2018-05-16       Impact factor: 5.243

2.  AβPP-selective BACE inhibitors (ASBI): novel class of therapeutic agents for alzheimer's disease.

Authors:  Olivier Descamps; Patricia Spilman; Qiang Zhang; Clare P Libeu; Karen Poksay; Olivia Gorostiza; Jesus Campagna; Barbara Jagodzinska; Dale E Bredesen; Varghese John
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

3.  Assessment of acetylcholinesterase activity using indoxylacetate and comparison with the standard Ellman's method.

Authors:  Miroslav Pohanka; Martina Hrabinova; Kamil Kuca; Jean-Pierre Simonato
Journal:  Int J Mol Sci       Date:  2011-04-18       Impact factor: 5.923

4.  New acetylcholinesterase inhibitors for Alzheimer's disease.

Authors:  Mona Mehta; Abdu Adem; Marwan Sabbagh
Journal:  Int J Alzheimers Dis       Date:  2011-12-15

5.  Synergistic Action of Flavonoids, Baicalein, and Daidzein in Estrogenic and Neuroprotective Effects: A Development of Potential Health Products and Therapeutic Drugs against Alzheimer's Disease.

Authors:  Roy C Y Choi; Judy T T Zhu; Amanda W Y Yung; Pinky S C Lee; Sherry L Xu; Ava J Y Guo; Kevin Y Zhu; Tina T X Dong; Karl W K Tsim
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-24       Impact factor: 2.629

6.  Sequencing, De novo Assembly, Functional Annotation and Analysis of Phyllanthus amarus Leaf Transcriptome Using the Illumina Platform.

Authors:  Aparupa Bose Mazumdar; Sharmila Chattopadhyay
Journal:  Front Plant Sci       Date:  2016-01-28       Impact factor: 5.753

7.  Galangin Suppresses Pro-Inflammatory Gene Expression in Polyinosinic-Polycytidylic Acid-Stimulated Microglial Cells.

Authors:  Min-Ji Choi; Jin-Sun Park; Jung-Eun Park; Han Su Kim; Hee-Sun Kim
Journal:  Biomol Ther (Seoul)       Date:  2017-11-01       Impact factor: 4.634

Review 8.  A Review on the Pharmacological Activities and Phytochemicals of Alpinia officinarum (Galangal) Extracts Derived from Bioassay-Guided Fractionation and Isolation.

Authors:  Aida Maryam Basri; Hussein Taha; Norhayati Ahmad
Journal:  Pharmacogn Rev       Date:  2017 Jan-Jun

Review 9.  Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.

Authors:  Khushwant S Bhullar; H P Vasantha Rupasinghe
Journal:  Oxid Med Cell Longev       Date:  2013-06-06       Impact factor: 6.543

10.  Wnt/β-catenin coupled with HIF-1α/VEGF signaling pathways involved in galangin neurovascular unit protection from focal cerebral ischemia.

Authors:  Chuanhong Wu; Jianxin Chen; Chang Chen; Wei Wang; Limei Wen; Kuo Gao; Xiuping Chen; Sihuai Xiong; Huihui Zhao; Shaojing Li
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.